Company Filing History:
Years Active: 2025
Title: Libero Vitiello: Innovator in Neuromuscular and Neuroinflammatory Treatments
Introduction
Libero Vitiello is a notable inventor based in Padua, Italy. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target various neuromuscular and neuroinflammatory diseases. His innovative work has the potential to improve the quality of life for both humans and animals.
Latest Patents
Libero Vitiello holds a patent for "Haloallylamine dual amine oxidase inhibitors." This invention relates to novel compounds capable of inhibiting semicarbazide-sensitive amine oxidase (SSAO/VAP-1) and monoamine oxidase B (MAO-B). These compounds are particularly useful for treating a variety of neuromuscular diseases, such as muscular dystrophies, and neuroinflammatory diseases affecting both peripheral and central systems in human subjects, as well as in pets and livestock. The patent also encompasses pharmaceutical compositions containing these compounds and various applications thereof. He has 1 patent to his name.
Career Highlights
Libero Vitiello is associated with Syntara Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges.
Collaborations
Some of his notable coworkers include Alan Duncan Robertson and Alison Dorothy Findlay. Their collaborative efforts contribute to the ongoing research and development in the field of pharmaceutical sciences.
Conclusion
Libero Vitiello's contributions to the field of neuromuscular and neuroinflammatory treatments highlight his role as an important inventor. His innovative compounds and ongoing research efforts have the potential to make a significant impact on healthcare.